Cannabis use in palliative care - an examination of the evidence and the implications for nurses

Journal of Clinical Nursing

Volumn 19, Issue 17-18, 2010, Pages 2454-2462

  Green, Anita J ^a   De Vries, Kay ^b  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b PRINCESS ALICE HOSPICE   (United Kingdom)

Author keywords

Cancer; Cannabis; Motor neurone disease; Multiple sclerosis; Palliative care; Quality of life

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CANNABIS SMOKING; EVIDENCE BASED MEDICINE; HUMAN; METHODOLOGY; MULTIPLE SCLEROSIS; NURSING CARE; PALLIATIVE THERAPY; QUALITY OF LIFE; UNITED KINGDOM;

AMYOTROPHIC LATERAL SCLEROSIS; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HUMANS; MARIJUANA SMOKING; MULTIPLE SCLEROSIS; NURSING CARE; PALLIATIVE CARE; QUALITY OF LIFE;

EID: 77955976146     PISSN: 09621067     EISSN: 13652702     Source Type: Journal    
DOI: 10.1111/j.1365-2702.2010.03274.x     Document Type: Article

References (61)

1. Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction 1996, 91:1585-1614.
2. Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT. Survey of cannabis use in patients with amyotrophic lateral sclerosis. American Journal of Hospice and Palliative Medicine 2004, 21:95-104.
3. Ashton CH. Adverse effects of cannabis and cannabinoids. British Journal of Anaesthesia 1999, 83:637-649.
4. Ashton H. Cannabis or health? Current Opinions in Psychiatry 2002, 15:247-253.
5. Bach L, Morland H. Acute cardiovascular fatalities following cannabis use. Forensic Science International 2001, 124:200-203.
6. Bagshaw SM, Hagen NA, Baker T. Medical efficacy of cannabinoids and marijuana: a comprehensive review of the literature. Journal of Palliative Care 2002, 18:111-122.
7. 2001, http://news.bbc.co.uk/1/hi/health/1423981.stm, (accessed 21 November 2008)
8. Berlach DM, Shir Y, Ware MA. Experience with synthetic cannabinoid Nabilone in chronic noncancer pain. Pain Medicine 2006, 7:25-29.
9. Berry EM, Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite. Pharmacological Therapy 2002, 95:185-190.
10. Therapeutic Uses of Cannabis 1997, Academic Publishers, London
11. Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. British Medical Journal 2001, 323:13-16.
12. Carter GT, Rosen BS. Marijuana in the management of amyotrophic lateral sclerosis. American Journal of Hospice and Palliative Care 2001, 18:264-270.
13. Carter GT, Ugalde V. Medical marijuana: emerging applications for the management of neurological disorders. Physical Medicine and Rehabilitation Clinics of North America 2004, 15:943-954.
14. Chatterjee A, Almahrezi A, Ware M, Fitzcharles M. A dramatic response to inhaled cannabis in a woman with central thalamic pain and dystonia. Journal of Pain and Symptom Management 2002, 24:4-6.
15. Clark AJ, Ware MA, Yazer E, Murray TJ, Lynch ME. Patterns of cannabis use among patients with multiple sclerosis. Neurology 2004, 62:2098-2100.
16. Consroe P, Musty R, Rein J, Tillery W, Pertwee R. The perceived effects of smoked cannabis on patients with multiple sclerosis. European Neurology 1997, 38:44-48.
17. Corner J, Plant H, A'Hern R, Bailey C. Non-pharmacological intervention for breathlessness in patients with lung cancer. Palliative Medicine 1996, 10:299-305.
18. Cotter J. Efficacy of crude marijuana and synthetic delta-9-tetrahydrocannabinol as treatment for chemotherapy-induced nausea and vomiting: a systematic literature review. Oncology Nursing Forum 2009, 36:342-352.
19. Misuse of Drugs Act 1971, HMSO, London
20. End of Life Care Strategy; Promoting High Quality Care for All Adults at the End of Life 2008, Department of Health, London
21. 2009, http://www.drugscope.org.uk/resources/drugsearch/drugsearchpages/cannabis.htm, (accessed 28 July 2009)
22. Information for Medical Doctors and Pharmacists 2003, Dutch Institute for Responsible Use of Medicine: Medicinal Cannabis, Office of Medicinal Cannabis, The Hague
23. Fox P, Bain PG, Glickman S, Carroll C, Zajicek J. The effects of cannabis on tremor in patients with multiple sclerosis. Neurology 2004, 62:1105-1109.
24. Frank B, Serpell MG, Hughes J, Mathews JNS, Kapur D. Comparison of analgesic effects and patient tolerability of nabilone and dihydrovodeine for chronic neuropathic pain: randomised, crossover, double blind study. BMJ 2008, http://www.bmj.com
25. Glare P, Aggarwal G, Clark K. Ongoing controversies in the pharmacological management of cancer pain. Internal Medicine Journal 2004, 34:45-49.
26. Gorter RW, Butorac M, Cobian EP, van der Sluis W. Medical use of cannabis in the Netherlands. Neurology 2005, 64:917-919.
27. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clinical Pharmacokine 2003, 42:327-360.
28. Guzmán M. Cannabinoids: potential anticancer agents. Nature Reviews 2003, 3:745-755.
29. GW Files Sativex®for Approval in Selected European Countries for MS Spasticity. 2006, http://www.gwpharm.com/sativex-ms-approval-europe.aspx, Available at:, accessed 28 July 2009
30. Hall W, Solowij N. Adverse effects of cannabis. Lancet 1998, 352:1611-1616.
31. Hays H. Marijuana for the management of proximal myotonic myopathy. Journal of Pain and Symptom Management 2001, 21:267-269.
32. Hirst RA, Lambert DG, Notcutt WG. Pharmacology and potential therapeutic use of cannabis. British Journal Anaesthesia 1998, 81:77-84.
33. Howard J, Kofi A, Holdcroft A, Korn S, Davies SC. Cannabis use in sickle cell disease: a questionnaire study. British Journal of Haematology 2005, 131:123-128.
34. Illhardt F, ten Have H. Research ethics in palliative care. The Ethics of Palliative Care 2002, 198-211. ten Have H, Clark D. eds, Open University Press, Buckingham
35. John G. The Independent [] 2000 Monday 3rd April, 2000. 2000, http://www.independent.co.uk/life-style/health-and-families/health-news/straw-supports-the-case-for-medical-use-of-cannabis-719057.html, (accessed 22 August 2009)
36. de Jong FA, Engels FK, Mathijssen RHJ, van Zuylen L, Verweij J. Medical cannabis in oncology practice: still a bridge too far? Journal of Clinical Oncology 2005, 23:2886-2891.
37. Kapur D. Shall we be using cannabis for pain control? Progress in Palliative Care 2003, 11:248-250. Editorial
38. Krenn H, Daha LK, Oczenski W. A case of cannabinoid rotation in a young woman with chronic cystitis. Journal of Pain and Symptom Management 2003, 25:3.
39. Kumar RN, Chambers WA, Pertwee RG. Pharmacological actions and therapeutic uses of cannabis and cannabinoids. Anaesthesia 2001, 56:1059-1068.
40. Lynch ME, Clark AJ. Cannabis reduces opioid dose in treatment of chronic non-cancer pain. Journal of Pain and Symptom Management 2003, 25:496-498.
41. Machado Rocha FC, Stéfano SC, De Cássia HR, Rosa Oliveira LMQ, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. European Journal of Cancer Care 2008, 17:431-443.
42. Mather L. Delivery systems for medicinal cannabis. Appendix D in the Report of the Working Party on the Use of Cannabis for Medicinal Purposes. 2000, http://www.druginfo.nsw.gov.au/druginfo/reports/medical_cannabis.html, Volume II: Main Report. NSW Government, Sidney.
43. Mathre ML, Krawitz M. Cannabis series - the whole story. Part 4: the medicinal use of Cannabis pre-prohibition. The Drug and Alcohol Professional 2002, 2:3-7.
44. McCarberg BH. Cannaboids: their role in pain and palliation. Journal of Pain & Palliative Care Pharmactherapy 2007, 21:3-19.
45. Musty R, Rossi R. Effects of smoked cannabis and oral Tetrahydrocannabinol on nausea and emesis after cancer chemotherapy: a review of state clinical trials. Journal of Cannabis Therapeutics 2000, 1:29-42.
46. Improving Supportive and Palliative Care for Adults with Cancer 2004, National Institute of Clinical Excellence, London
47. Notcutt W. Cannabis and pain control. European Journal of Palliative Care 2004, 11:6-230.
48. The Code. Standards of Conduct, Performance and Ethics for Nurses and Midwives 2008, NMC, London
49. 2009, http://www.palliativedrugs.com, (accessed 22 August 2009
50. 2009, http://www.patient.co.uk/showdoc/40025213/, (accessed 22 August 2009)
51. Cannabis: the scientific and medical evidence 1998, House of Commons Library Research Paper, London
52. 2nd Report on the Therapeutic Uses of Cannabis 2000, House of Commons Library Research Paper, London
53. Shapiro H. Telephone Conversation 2009, 24th November 2009, Director of Communications and information, DrugScope, London
54. Smith D. The Telegraph. 2009, http://www.telegraph.co.uk/comment/personal-view/5942142/Abandon-the-war-on-drugs-but-start-a-war-on-addiction.html, (accessed 22 August 2009)
55. Tramer MR, Carroll D, Campbell FA. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. British Medical Journal 2001, 323:16-21.
56. Wade DT, Robson P, House H, Makela P, Aram J. A preliminary controlled study to determine whether wholeplant cannabis extracts can improve intractable neurogenic symptoms. Clinical Rehabilitation 2003, 17:18-26.
57. Walton RP. Cannabis indica in pharmaceuticals. Journal of the Medical Society of New Jerse 34, Cited: Mathre ML and Krawitz M 2002 Cannabis series - the whole story. Part 4: the medicinal use of Cannabis pre-prohibition. The Drug and Alcohol Professional 1938, 2:3-7.
58. Watson M, Lucas C, Hoy A, Back I. Oxford Handbook of Palliative Care 2005, Oxford University Press, Oxford
59. Wilbourn M, Prosser S. The Pathology and Pharmacology of Mental Illness 2003, Nelson Thornes, Cheltenham
60. Woolridge E, Barton S, Samuel J, Osorio J, Dougherty A, Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management 2005, 29:358-367.
61. Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A. Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAM study): multicentre randomised placebo-controlled trial. Lancet 2003, 362:1517-1525.